Publications by authors named "Amit Bhate"

Claim this Profile
E
Effectiveness and Safety of Glycopyrronium-Formoterol-Budesonide Triple Therapy in Chronic Obstructive Pulmonary Disease (AIR-FORCE): An Open-Label Multi-Centric Phase 4 Study.
Anjali R Nath, Adesh Kumar, Amit Suresh Bhate, Bharat Mehrotra, Deependra Kumar Rai

Adv Respir Med· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of novel fixed dose combination of vilanterol, glycopyrronium, and fluticasone furoate dry powder inhaler: A phase 3, randomized, non-inferiority trial compared with fixed dose combination of indacaterol, glycopyrronium, and mometasone furoate dry powder inhaler in Indian asthma patients.
Chintan Patel, Vaishal Sheth, Ravi Koppula, Avadhesh Kumar, Amit S Bhate

Respir Med· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of heterologous intranasal iNCOVACC vaccination as a booster to two-dose intramuscular Covid-19 vaccination series: a randomized phase 3 clinical trial.
Venkateshwar Rao Akula, Amit Suresh Bhate, Chandrasekhar S Gillurkar, Jitendra Singh Kushwaha, Ajeet Pratap Singh

Commun Med (Lond)· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prospective, Open-Label, Observational, Multicenter, Single Arm, Post-Marketing Study in Asthmatic Patients for Evaluation of Safety and Effectiveness of Indacaterol/Mometasone DPI (PROMISING-SHIFT).
Saurabh Karmakar, Gajendra V Singh, Amit S Bhate, Vijaykumar Barge, Bharat Mehrotra

Adv Respir Med· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Are Two Gliflozins Different: A Prospective Multicenter Randomized Study to Assess Effect of Remogliflozin Compared With Empagliflozin on Biomarkers of Heart Failure in Indian Patients With Type 2 Diabetes Mellitus with Chronic Heart Failure (REMIT-HF Study).
Shantanu Sengupta, Jayagopal Pathiyilbalagopalan, Ashwani Mehta, J P S Sawhney, Satish Suryavanshi, Amit Bhate

J Card Fail· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A prospective, multicentre study evaluating safety and efficacy of a fixed dose combination of Remogliflozin etabonate, Vildagliptin, and Metformin in Indian patients with type 2 diabetes mellitus (Triad-RMV).
Prabhat K Agarwal, Divendu Bhushan, Amit Bhate, Sunil Naik, Shailesh Adwani

Clin Diabetes Endocrinol· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of a bivalent (D614 + B.1.351) SARS-CoV-2 recombinant protein vaccine with AS03 adjuvant in adults: a phase 3, parallel, randomised, modified double-blind, placebo-controlled trial.
Gustavo H Dayan, Nadine Rouphael, Stephen R Walsh, Aiying Chen, Nicole Grunenberg, Amit Suresh Bhate

Lancet Respir Med· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of a monovalent (D614) SARS-CoV-2 recombinant protein vaccine with AS03 adjuvant in adults: a phase 3, multi-country study.
Gustavo H Dayan, Nadine Rouphael, Stephen R Walsh, Aiying Chen, Nicole Grunenberg, Amit Suresh Bhate

EClinicalMedicine· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase III Pivotal comparative clinical trial of intranasal (iNCOVACC) and intramuscular COVID 19 vaccine (Covaxin).
Chandramani Singh, Savita Verma, Prabhakar Reddy, Michael S Diamond, David T Curiel, Amit Suresh Bhate

NPJ Vaccines· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of a bivalent (D614 + B.1.351) SARS-CoV-2 Protein Vaccine.
Gustavo H Dayan, Nadine Rouphael, Stephen R Walsh, Aiying Chen, Nicole Grunenberg, Amit Suresh Bhate

medRxiv· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Persistence of immunity and impact of third dose of inactivated COVID-19 vaccine against emerging variants.
Krishna Mohan Vadrevu, Brunda Ganneru, Siddharth Reddy, Harsh Jogdand, Dugyala Raju, Amit Bhate

Sci Rep· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine, BBV152: interim results from a double-blind, randomised, multicentre, phase 2 trial, and 3-month follow-up of a double-blind, randomised phase 1 trial.
Raches Ella, Siddharth Reddy, Harsh Jogdand, Vamshi Sarangi, Brunda Ganneru, Amit Bhate

Lancet Infect Dis· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Oro-facial-digital syndrome type II.
Meenakshi Kalyan, S Kanitkar, Robby John, G Gireesh, Amit Bhate

J Assoc Physicians India· October 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predictors of competing mortality in advanced head and neck cancer.
Loren K Mell, James J Dignam, Joseph K Salama, Ezra E W Cohen, Blase N Polite, Amit D Bhate

J Clin Oncol· January 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Palliative radiation therapy in the management of brain metastases, spinal cord compression, and bone metastases.
Samir V Sejpal, Amit Bhate, William Small

Semin Intervent Radiol· December 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Image guided I125 prostate brachytherapy with Hybrid Interactive Mick technique in the community setting: How does it compare?
Thomas G Shanahan, Paul W Mueller, David A Roszhart, William C Severino, Amit D Bhate

Technol Cancer Res Treat· April 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis